Corbus Pharmaceuticals Holdings Inc. (CRBP) stock lost in the after-hours on Thursday?
Corbus Pharmaceuticals Holdings Inc. (CRBP) shares declined 2.90% in after-hours on Thursday, June 24, 2021, and closed the day at $2.01 per share. Earlier in the morning session, CRBP’s stock gained 4.02% to close the session at $2.07 per share. CRBP shares have fallen 73.99% over the last 12 months, and they have moved down […]
Corbus Pharmaceuticals Holdings Inc. (CRBP) stock plunged during current market. Let’s find out why?
Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) stock fell by 11.31% during the current trading session. By expanding on their core knowledge in immunology, Corbus is committed to linking innovation to their goal of helping lives by discovering novel medications that address inflammation, fibrosis, metabolism, and immuno-oncology. >> 7 Top Picks for the Post-Pandemic Economy << […]
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Undergoes Minor Volatility Following New Licensing Deals
Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock prices were down by a concerning 5.53% as of the market closing, bringing the price per share down to USD$2.05 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 1.46%, bringing it up to USD$2.08. New Licensing Deals June 1st, 2021 saw […]
